These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 26677046)

  • 1. Rho kinase inhibitors for glaucoma treatment - Review.
    Germano RA; Finzi S; Challa P; Susanna Junior R
    Arq Bras Oftalmol; 2015; 78(6):388-91. PubMed ID: 26677046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho-associated kinase inhibitors: a novel glaucoma therapy.
    Inoue T; Tanihara H
    Prog Retin Eye Res; 2013 Nov; 37():1-12. PubMed ID: 23770081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.
    Rao PV; Pattabiraman PP; Kopczynski C
    Exp Eye Res; 2017 May; 158():23-32. PubMed ID: 27593914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma.
    Honjo M; Tanihara H
    Jpn J Ophthalmol; 2018 Mar; 62(2):109-126. PubMed ID: 29445943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Rho Kinase Inhibitors on Intraocular Pressure and Aqueous Humor Dynamics in Nonhuman Primates and Rabbits.
    Toris CB; McLaughlin MA; Dworak DP; Fan S; Havens S; Zhan GL; Horan N; Prasanna G
    J Ocul Pharmacol Ther; 2016; 32(6):355-64. PubMed ID: 27266531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting outflow facility in glaucoma management.
    Brubaker RF
    Surv Ophthalmol; 2003 Apr; 48 Suppl 1():S17-20. PubMed ID: 12852430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma.
    Rao VP; Epstein DL
    BioDrugs; 2007; 21(3):167-77. PubMed ID: 17516712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho/Rho-associated kinase pathway in glaucoma (Review).
    Wang J; Liu X; Zhong Y
    Int J Oncol; 2013 Nov; 43(5):1357-67. PubMed ID: 24042317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits.
    Isobe T; Mizuno K; Kaneko Y; Ohta M; Koide T; Tanabe S
    Curr Eye Res; 2014 Aug; 39(8):813-22. PubMed ID: 24502505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of prostaglandins on aqueous humour dynamics and intraocular pressure].
    Raber T
    Klin Monbl Augenheilkd; 2005 Oct; 222(10):802-6. PubMed ID: 16240273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho-kinase inhibitors in the management of glaucoma.
    Berrino E; Supuran CT
    Expert Opin Ther Pat; 2019 Oct; 29(10):817-827. PubMed ID: 31573364
    [No Abstract]   [Full Text] [Related]  

  • 12. Rho-kinase (ROCK) Inhibitors - A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility.
    Abbhi V; Piplani P
    Curr Med Chem; 2020; 27(14):2222-2256. PubMed ID: 30378487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho Kinase (ROCK) Inhibitors for the Treatment of Glaucoma.
    Wu J; Wei J; Chen H; Dang Y; Lei F
    Curr Drug Targets; 2024; 25(2):94-107. PubMed ID: 38155465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of Rho-associated protein kinase inhibitors for glaucoma treatment.
    Colligris B; Crooke A; Huete F; Pintor J
    Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):89-98. PubMed ID: 22533522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel inhibitors for the treatment of glaucoma.
    Cholkar K; Trinh HM; Pal D; Mitra AK
    Expert Opin Drug Discov; 2015 Mar; 10(3):293-313. PubMed ID: 25575654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Application of Rho Kinase Inhibitors in the Management of Glaucoma.
    Liu LC; Chen YH; Lu DW
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMPs in the trabecular meshwork: promising targets for future glaucoma therapies?
    De Groef L; Van Hove I; Dekeyster E; Stalmans I; Moons L
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7756-63. PubMed ID: 24265206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations.
    Andrés-Guerrero V; García-Feijoo J; Konstas AG
    Adv Ther; 2017 May; 34(5):1049-1069. PubMed ID: 28349508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension.
    Tanna AP; Johnson M
    Ophthalmology; 2018 Nov; 125(11):1741-1756. PubMed ID: 30007591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics.
    Van de Velde S; De Groef L; Stalmans I; Moons L; Van Hove I
    Prog Neurobiol; 2015 Aug; 131():105-19. PubMed ID: 26093354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.